Inogen (INGN) News Today $9.16 +0.13 (+1.44%) (As of 03:39 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Inogen (NASDAQ:INGN) Shares Pass Below 200-Day Moving Average - Here's WhyOctober 31, 2024 | americanbankingnews.comInogen (INGN) Set to Announce Quarterly Earnings on ThursdayInogen (NASDAQ:INGN) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636745)October 31, 2024 | marketbeat.comInogen (NASDAQ:INGN) Stock Passes Below 200 Day Moving Average - Here's WhyInogen (NASDAQ:INGN) Stock Price Passes Below 200 Day Moving Average - Should You Sell?October 23, 2024 | marketbeat.comSanctuary Advisors LLC Acquires Shares of 80,075 Inogen, Inc. (NASDAQ:INGN)Sanctuary Advisors LLC bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,075 shares of the medical technologyOctober 15, 2024 | marketbeat.comInogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC ChallengesOctober 9, 2024 | finance.yahoo.comInogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POCOctober 8, 2024 | finance.yahoo.comMarshall Wace LLP Cuts Stock Holdings in Inogen, Inc. (NASDAQ:INGN)Marshall Wace LLP decreased its position in Inogen, Inc. (NASDAQ:INGN - Free Report) by 62.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 125,205 shares of the medical technology company's stock after selOctober 8, 2024 | marketbeat.comB. Riley Wealth Advisors Inc. Buys Shares of 56,200 Inogen, Inc. (NASDAQ:INGN)B. Riley Wealth Advisors Inc. bought a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 56,200 shares of the medical technology company'October 7, 2024 | marketbeat.comAQR Capital Management LLC Raises Stock Holdings in Inogen, Inc. (NASDAQ:INGN)AQR Capital Management LLC boosted its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 570,994 shares of the medical technology company's stock after buyiOctober 6, 2024 | marketbeat.comInogen (NASDAQ:INGN) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comInogen: Upside Seems Limited After Big Move UpSeptember 24, 2024 | seekingalpha.comInogen, Inc. (NASDAQ:INGN) Position Increased by Divisadero Street Capital Management LPDivisadero Street Capital Management LP increased its holdings in Inogen, Inc. (NASDAQ:INGN - Free Report) by 682.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,346,766 shares of the medical technology company's stSeptember 20, 2024 | marketbeat.comMonaco Asset Management SAM Purchases New Holdings in Inogen, Inc. (NASDAQ:INGN)Monaco Asset Management SAM purchased a new stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 75,000 shares of the medical technology company's stock, valued atSeptember 10, 2024 | marketbeat.comInogen Appoints Eric Pauls as Vice President of Sales, North AmericaSeptember 6, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Sees Large Decline in Short InterestInogen, Inc. (NASDAQ:INGN - Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,350,000 shares, a decline of 8.2% from the July 15th total of 1,470,000 shares. Based on an average daily trading volume, of 224,000 shares, the short-interest ratio is presently 6.0 days.August 18, 2024 | marketbeat.comVanguard Group Inc. Increases Position in Inogen, Inc. (NASDAQ:INGN)Vanguard Group Inc. boosted its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,424,026 shares of the mediAugust 14, 2024 | marketbeat.comInogen (NASDAQ:INGN) Upgraded to Hold at StockNews.comStockNews.com raised Inogen from a "sell" rating to a "hold" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comInogen, Inc. (NASDAQ:INGN) Analysts Are Pretty Bullish On The Stock After Recent ResultsAugust 10, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Issues Earnings Results, Beats Expectations By $0.31 EPSInogen (NASDAQ:INGN - Get Free Report) announced its earnings results on Tuesday. The medical technology company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.55) by $0.31. Inogen had a negative return on equity of 42.87% and a negative net margin of 30.07%. The company had revenue of $88.77 million for the quarter, compared to analyst estimates of $82.50 million. During the same quarter last year, the company earned ($0.42) earnings per share. The firm's quarterly revenue was up 6.1% compared to the same quarter last year.August 9, 2024 | marketbeat.comInogen Shares Rally Premarket After 2Q Results Top ViewsAugust 7, 2024 | marketwatch.comInogen, Inc. (NASDAQ:INGN) Q2 2024 Earnings Call TranscriptAugust 7, 2024 | insidermonkey.comInogen's (INGN) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Inogen in a report on Wednesday.August 7, 2024 | marketbeat.comInogen Announces Second Quarter 2024 Financial ResultsAugust 6, 2024 | finance.yahoo.comStockNews.com Downgrades Inogen (NASDAQ:INGN) to SellStockNews.com lowered shares of Inogen from a "hold" rating to a "sell" rating in a research report on Monday.August 5, 2024 | marketbeat.comInogen is about to announce its earnings — here's what Wall Street expectsAugust 5, 2024 | markets.businessinsider.comJacobs Levy Equity Management Inc. Has $3.01 Million Stake in Inogen, Inc. (NASDAQ:INGN)Jacobs Levy Equity Management Inc. cut its stake in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 19.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 372,338 shares of the medical technology company's stock afterAugust 1, 2024 | marketbeat.comInogen (NASDAQ:INGN) investors are sitting on a loss of 88% if they invested three years agoJuly 29, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Stock Rating Upgraded by StockNews.comStockNews.com upgraded shares of Inogen from a "sell" rating to a "hold" rating in a research report on Saturday.July 27, 2024 | marketbeat.com3 Stocks Under $10 With the Potential for Massive GainsJuly 22, 2024 | investorplace.com3 Stocks Under $10 With the Potential for Massive GainsJuly 22, 2024 | investorplace.comOfferpad Solutions: Now Is The Time To Go Against The CrowdJuly 21, 2024 | seekingalpha.comInogen (NASDAQ:INGN) Cut to Sell at StockNews.comStockNews.com lowered shares of Inogen from a "hold" rating to a "sell" rating in a research report on Friday.July 19, 2024 | marketbeat.comInogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business DevelopmentJuly 3, 2024 | businesswire.comBrown Capital Management LLC Has $8.57 Million Holdings in Inogen, Inc. (NASDAQ:INGN)Brown Capital Management LLC lessened its position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 29.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,560,409 shares of the medical technology comJune 13, 2024 | marketbeat.comInsider Selling: Inogen, Inc. (NASDAQ:INGN) EVP Sells 10,000 Shares of StockMay 15, 2024 | insidertrades.comJason Somer Sells 10,000 Shares of Inogen, Inc. (NASDAQ:INGN) StockInogen, Inc. (NASDAQ:INGN - Get Free Report) EVP Jason Somer sold 10,000 shares of the company's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $8.56, for a total transaction of $85,600.00. Following the transaction, the executive vice president now owns 4,452 shares in the company, valued at approximately $38,109.12. The sale was disclosed in a filing with the SEC, which can be accessed through this link.May 14, 2024 | marketbeat.comStifel Nicolaus Reaffirms Their Hold Rating on Inogen (INGN)May 9, 2024 | markets.businessinsider.comEarnings Update: Here's Why Analysts Just Lifted Their Inogen, Inc. (NASDAQ:INGN) Price Target To US$7.00May 9, 2024 | finance.yahoo.comInogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Posts Quarterly Earnings Results, Beats Expectations By $0.14 EPSInogen (NASDAQ:INGN - Get Free Report) announced its quarterly earnings results on Tuesday. The medical technology company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.76) by $0.14. The business had revenue of $78.03 million for the quarter, compared to the consensus estimate of $73.67 million. Inogen had a negative return on equity of 38.98% and a negative net margin of 32.46%. The business's revenue was up 8.1% compared to the same quarter last year. During the same period last year, the business posted ($0.63) EPS.May 8, 2024 | marketbeat.comQ1 2024 Inogen Inc Earnings CallMay 8, 2024 | finance.yahoo.comInogen (NASDAQ:INGN) Price Target Raised to $7.00 at Stifel NicolausStifel Nicolaus upped their price target on shares of Inogen from $6.00 to $7.00 and gave the company a "hold" rating in a report on Wednesday.May 8, 2024 | marketbeat.comInogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ...May 8, 2024 | finance.yahoo.comINGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | investorplace.comInogen: Q1 Earnings SnapshotMay 7, 2024 | washingtonpost.comInogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on GrowthMay 7, 2024 | finance.yahoo.comInogen Announces First Quarter 2024 Financial ResultsMay 7, 2024 | businesswire.comInogen, Inc. (NASDAQ:INGN) Stock Position Lifted by Federated Hermes Inc.Federated Hermes Inc. grew its holdings in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) by 347.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 265,485 shares of the medical technology company's stock after purchasing an additional 206,12April 30, 2024 | marketbeat.comInogen: New Management And A Major Competitor Exit Offer Some New OpportunitiesApril 13, 2024 | seekingalpha.comInogen to Report First Quarter 2024 Financial Results on May 7, 2024April 10, 2024 | businesswire.com Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to play the AI boom (act before November 19) (Ad)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as little as $16 and a brokerage account. Click here to get the ticker >>> INGN Media Mentions By Week INGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INGN News Sentiment▼0.550.44▲Average Medical News Sentiment INGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INGN Articles This Week▼22▲INGN Articles Average Week Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jin Medical International News Sanara MedTech News Lakeland Industries News Nutriband News Alpha Pro Tech News Milestone Scientific News Envoy Medical News Vicarious Surgical News CollPlant Biotechnologies News ReWalk Robotics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INGN) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredNASDAQ small cap that could be gearing up for a massive short squeeze.A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!Huge Alerts | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
